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This editorial paper reports on our experience in introducing augmented
reality (AR) in interventional neuroradiology environments. Our expectations
about the next AR tools, in particular for more advanced visualization, are
also put forward. For practical reasons, the references will be restricted to our
contributions. For further information, the last recommendations concerning the
medical management of aneurysm induced hemorrhages can be found in [1].
1 Interventional neuroradiology
Interventional neuroradiology is a medical discipline that leverages minimally
invasive techniques to operate on vascular lesions of the nervous system. The
treatment is performed through the inside of the blood vessels, using medical
imaging as visual feed-back. Such endovascular procedures are mainly performed
to treat aneurysms. Intracranial aneurysms are sacciform ectasias of arteries
located on the brain surface. The main associated risk is their rupture, leading to
an hemorrhage with dramatic clinical consequences. Their size (diameter) varies
between 2 mm and a few tens of millimeters. An endovascular treatment (EVT)
progressively occludes the aneurysm with very soft spiral-like coils. EVTs were
introduced in the 60’s but really took off in the 90’s after controlled detachable
coils were developed. EVT has now replaced neurosurgery as the first choice
treatment of aneurysms.
EVTs are performed in interventional vascular operating rooms where X-ray
imaging enables the precise analysis of the lesions and their treatment. X-ray
Angiography still remains the imaging modality of reference thanks to its op-
timal spatial and temporal resolution. The endovascular navigation followed by
the EVT itself are performed under the real-time visual feed-back of a low dose
and high frame rate (15 fps on average) angiography image acquisition called
fluoroscopy. However, these low quality images are projection images that do
not contain any 3D information. Several viewpoints are required for an easier
guidance through complex vascular networks and a better control of the treat-
ment. Therefore aneurysm EVT are usually performed in biplane mode, provid-
ing simultaneous Antero-Posterior (AP) and Lateral (Lat) fluoroscopic views.
No significant improvements were brought in the last few years in the control of
EVTs using fluoroscopy. The development of Augmented Fluoroscopy very re-
cently modified this status by introducing, for the first time, Augmented Reality
in vascular interventional neuroradiology.
2 Augmented Fluoroscopy: principle and clinical interest
The idea of enriching fluoroscopy images with 3D data was born shortly after the
development, in 1997, of 3D rotational angiography (3DRA) [2], a cone-beam
tomography reconstruction techniques that produces a volume from angiogra-
phy images acquired during a rotation of the vascular C-arm. 3DRA allows for
an optimal treatment planning thanks to a precise analysis of the aneurysm
morphology: its size, its shape and its neck, where it connects with its parent
vessel [3]. From 3DRA, a working view can be defined that best identifies the
aneurysmal neck and clearly reveals the limits for the coil positioning. 3DRA
rapidly became a must-have imaging modality for EVT planning, to improve
treatment safety and expand their indications. However, over a decade was nec-
essary to actually integrate 3DRA with fluoroscopy thereby building the first
augmented reality tool suitable for use in clinical practice.
During EVT, superimposing 3DRA onto the fluoroscopy sequence provides
the physician with a stereoscopic vision of the morphology of vascular bifurca-
tions, of the aneurysm and its relations with neighboring vessels. Endovascular
guidance is made easier and coil deployment is better controlled.
Augmented Fluoroscopy (AF) is based on 3D/2D registration between 3DRA
and fluoroscopy in any C-arm orientation. A prototype was developed in close
collaboration between the research team (Inria Nancy Grand-Est), the manufac-
turer (GE Healthcare) and the medical staff (Department of Neuroradiology Uni-
versity Hospital of Nancy, France). The geometric accuracy of the implemented
machine-based registration was first measured [4]. The next step consisted in
further evaluating the prototype in the clinical conditions of an aneurysm EVT.
Validation criteria were designed to address the clinical requirements met in the
operating room, in terms of geometric accuracy and visualization. Visualization
should indeed both preserve the visibility of the EVT tools (microcatheters,
guidewires, and coils) and clearly depict the vascular topology in 3D.
The geometric accuracy was first estimated on a silicon phantom of the cere-
bral vasculature under various orientations of the C-arm. It was proved to be
less than 0.5 mm and therefore compatible with the clinical objective [5]. This
first conclusion was confirmed on clinical cases.
Concerning visualization, we chose to blend the 3DRA volume in Volume
Rendering onto the fluoroscopic images. Easy to implement, this solution presents
as a further advantage that it barely impacts the usual physician’s environment
(see Figure 1). Using AF in clinical conditions confirmed the relevance of this
choice, and helped to significantly improve this prototype with functionalities
such as interactive tuning of the vessel transparency to reach an optimal con-
sensus between vascular relief and envovascular material visibility. After these
successive improvements, AF was launched as a product in 2007.
Fig. 1. Augmented Fluoroscopy (AF) case. (left) Original fluoroscopy image ; (right)
AF view. AF offers a much clearer depiction of the ruptured aneurysm to be treated
(green circle), and also unveils a microscopic incidental aneurysm which hampers the
guide wire navigation (red arrow).
3 The ordeal of going into clinical practice: an
under-estimated step
The medical team was involved in the development of AF right from the start,
and the preliminary evaluation demonstrated its definite clinical interest. Nev-
ertheless, several limitations made the integration of AF in clinical routine very
gradual. First, AF is only available on the AP C-arm. Yet, in biplane mode, the
working view used for the EVT may only be reached by the Lat C-arm. Second,
in actual clinical practice, many events may cause the machine-based registra-
tion to degrade which quite often calls for a manual correction in the absence of
an image-based registration adjustment.
Moreover, the AF monitor was first set aside in the operating room in order
to minimize the perturbation on the otherwise unchanged environment. On one
hand, the physicians readily accepted such a discrete modification in their work
environment. On the other hand, the prototype was underutilized. Therefore,
significant improvements, in terms of ergonomics, were made to better integrate
the prototype into the operating room, such as larger zoom factors and an actual
integration as part of the panel of control monitors.
The second step towards the use in clinical routine was gradual and more or
less fast depending on physicians. Indeed, physicians needed some time to agree
to change their work routine either during risky interventions that required a
lot of concentration or for cases they could easily treat without AF. But this
phase, including, and especially for the latter simple cases, proved essential to the
evaluation by physicians who had to become familiar with the new environment
and compare it with reference tools, namely casual fluoroscopy that was still
available. Once AF was mastered, the physician could use it in complex cases
and rely on information that would not be accessible with mere fluoroscopy, e.g.
axial views of complex aneurysms. AF is being used in clinical routine at our
institution since 2011.
4 Perspectives: other applications of Augmented
Fluoroscopy ; needs for further Augmented Reality
tools
AFmarks a breakthrough in intraoperative visualization by introducing the third
dimension. It was perfectly integrated into the EVT environment for intracranial
aneurysms. Its use for other clinical applications and in combination with other
3D imaging modalities were logically pursued.
Arteriovenous malformations (AVMs) are scarcer than brain aneurysms and
also differ a lot on both the morphology and therapy levels. They consist of a
network of abnormal vessels interposed between arteries and veins which creates
a high blood speed arteriovenous shunt in the brain parenchyma. The treatment
is to occlude the AVM using fluid or pasty injections after a distal navigation
within a very small, sub-millimetric, highly branched vascular network. Techno-
logical advances in the field of navigation tools and endovascular material allow
to perform such embolization in very distal vascular areas, as well as highly
functional brain regions.
AF can facilitate this complex navigation by displaying the origin and path of
afferent arteries and differentiating them from neighboring vessels or vessels that
superimpose in the fluoroscopic view. These clinical needs are more demanding
than for aneurysms given the complexity and finesse of the vascular network.
Additional work in terms of accuracy of registration, and vascular segmenta-
tion and visualization will be necessary to make this tool functional in clinical
practice.
During an EVT, the physician can only see vessels on the monitors, but has
no access to a direct visualization of the cerebral parenchyma in the surroundings
of the endovascular material. Locating crucial functional brain areas cannot be
realized but through a mental effort to relate a priori anatomical knowledge and
preoperative imaging to intraoperative views. The inherent inaccuracy of such
process may lead the physician to excessively embolize in highly functional areas,
potentially causing dramatic complications, or, conversely to give up treatment
in case of doubt. A multimodal localization is definitely required, especially
combining MRI and angiography, to identify the cerebral regions with a high
accuracy. Innovative visualization tools will have to be developed to setup such
new multimodality environments and bring relevant information, in an intuitive
way, to the physician during the treatment.
During the treatement, AF provides 3D vascular information in any orienta-
tion the C-arm can reach. As such, a real progress was made compared to mere
fluoroscopy imaging. However, endovascular material still is only visible under
projection in limited orientations. The next step will see the 3D reconstruction
of endovascular tools and material during the EVT. These tools and material
will be directly located in the 3DRA volume and thereby, on one hand, visible in
any view, including virtual views, such as axial views inaccessible to the C-arm,
and on the other hand, easy to relate to any 3D multimodal imaging volume.
Very hard technical and scientific issues will have to be overcome, but it casts a
glimpse of potentially dramatic breakthroughs in the way EVTs are performed.
Having such a possibility will allow for a better control of the EVT, thus
improving safety. However working in a multimodal environment will generate
inaccuracies due to the involved registration and segmentation processes, that
will need to be quantified and that the physician should be fully aware of. The
physician will have to agree to cope with this uncertainty when working on
virtual views without the direct control provided by fluoroscopy, and thus no
possibility for correction. An important intellectual investment will be necessary
to learn how to use these tools and manage this uncertainty before appropriating
these tools in clinical practice.
Eventually, future augmented environments will be enriched not only with
visual information from other imaging modalities such as functional, but also
with other data such as generated by hemodynamic simulation or wall pressure
computations for aneurysms.
5 Conclusion
Our experience with AF shows it is possible to develop Augmented Reality tools
in the field of interventional neuroradiology. But there is a long way between the
initial idea and the product used in clinical practice: 10 years in the case of AF.
For this tool to be used it must meet specific clinical needs, clearly identified
by physicians, and be validated for this purpose. This validation must meet spe-
cific criteria and objectives. In the case of an EVT, which corresponds to a risky
procedure requiring a high concentration from the physician, any Augmented
Reality tool must be fully integrated into the operating room and provide an
intuitive interface.
It is important that any operator that was not necessarily involved in the
development and validation process, be persuaded to use the tool first in simple
cases where it can be evaluated within a personal operating environment so as
to gradually become more familiar with the tool and finally trust the additional
information it provides. Under these conditions the augmented environment has
the potential to bring real benefits to the physician, especially in complex cases,
and imply actual changes in the clinical practice. As an example, AF provides
actual 3D information which biplane fluoroscopy useless for most interventions
and thus reduceing patient irradiation and exam time while probably improving
the safety of the intervention.
AF has paved the way for Augmented Reality in interventional neuroradi-
ology. A vast field of opportunities exist to adapt this tool to other, more de-
manding, clinical applications and develop new Augmented Reality tools. New
angiographic rooms will emerge that integrate an augmented environment, al-
lowing the interventional neuroradiologist to work in fully multimodal setup
enriched with visual, and other kinds of, information.
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